Generic placeholder image

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Author(s): Khyber Shinwari*, Mikhail Bolkov, Irina A. Tuzankina and Valery A. Chereshnev

DOI: 10.2174/1871523019999200730171600

DownloadDownload PDF Flyer Cite As
Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review

Page: [132 - 149] Pages: 18

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Introduction: Newborn screening (NBS) by quantifying T cell receptor excision circles (TRECs) and Kappa receptor excision circles in neonatal dried blood spots (DBS) enables early diagnosis of different types of primary immune deficiencies. Global newborn screening for PID, using an assay to detect T-cell receptor excision circles (TREC) in dried blood spots (DBS), is now being performed in all states in the United States. In this review, we discuss the development and outcomes of TREC, TREC/KREC combines screening, and continued challenges to implementation.

Objective: To review the diagnostic performance of published articles for TREC and TREC/ KREC based NBS for PID and its different types.

Methods: Different research resources were used to get an approach for the published data of TREС and KREC based NBS for PID like PubMed, Scopus, Google Scholar, Research gate EMBASE. We extracted TREC and KREC screening Publisher with years of publication, content and cut-off values, and a number of retests, repeat DBS, and referrals from the different published pilot, pilot cohort, Case series, and cohort studies.

Results: We included the results of TREC, combined TREC/KREC system based NBS screening from different research articles, and divided these results between the Pilot studies, case series, and cohort. For each of these studies, different parameter data are excluded from different articles. Thirteen studies were included, re-confirming 89 known SCID cases in case series and reporting 53 new SCID cases in 3.15 million newborns. Individual TREC contents in all SCID patients were <25 TRECs/μl (except in those evaluated with the New York State assay).

Conclusion: TREC and KREC sensitivity for typical SCID and other types of PID was 100 %. It shows its importance and anticipating the significance of implementation in different undeveloped and developed countries in the NBS program in upcoming years. Data adapting the screening algorithm for pre-term/ill infants reduce the amount of false-positive test results.

Keywords: Primary immunodeficiency, severe combined immunodeficiency, T-cell lymphopenia, newborn screening, T-cell receptor excision circles, kappa-recombination excision circle, algorithm.

[1]
Papadopoulou-Alataki, E.; Hassan, A.; Davies, E.G. Prevention of infection in children and adolescents with primary immunodeficiency disorders. Asian Pac. J. Allergy Immunol., 2012, 30(4), 249-258.
[PMID: 23393904]
[2]
Aghamohammadi, A.; Mohammadinejad, P.; Abolhassani, H.; Mirminachi, B.; Movahedi, M.; Gharagozlou, M.; Parvaneh, N.; Zeiaee, V.; Mirsaeed-Ghazi, B.; Chavoushzadeh, Z.; Mahdaviani, A.; Mansouri, M.; Yousefzadegan, S.; Sharifi, B.; Zandieh, F.; Hedayat, E.; Nadjafi, A.; Sherkat, R.; Shakerian, B.; Sadeghi-Shabestari, M.; Hosseini, R.F.; Jabbari-Azad, F.; Ahanchian, H.; Behmanesh, F.; Zandkarimi, M.; Shirkani, A.; Cheraghi, T.; Fayezi, A.; Mohammadzadeh, I.; Amin, R.; Aleyasin, S.; Moghtaderi, M.; Ghaffari, J.; Arshi, S.; Javahertrash, N.; Nabavi, M.; Bemanian, M.H.; Shafiei, A.; Kalantari, N.; Ahmadiafshar, A.; Khazaei, H.A.; Atarod, L.; Rezaei, N. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J. Clin. Immunol., 2014, 34(4), 478-490.
[http://dx.doi.org/10.1007/s10875-014-0001-z] [PMID: 24659230]
[3]
Riaz, I.B.; Faridi, W.; Patnaik, M.M.; Abraham, R.S. A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity). Front. Immunol., 2019, 10, 777.
[http://dx.doi.org/10.3389/fimmu.2019.00777] [PMID: 31057537]
[4]
Hauck, F.; Voss, R.; Urban, C.; Seidel, M.G. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders. J. Allergy Clin. Immunol., 2018, 141(1), 59-68.e4.
[http://dx.doi.org/10.1016/j.jaci.2017.06.009] [PMID: 28669558]
[5]
Al-Herz, W.; Bousfiha, A.; Casanove, J.L.; Chatila, T.; Conley, M.E. Cunningham, Rundles.; Etzioni, A.; France, J.L.; Gaspar, H.B.; Holland, S.M.; Christoph, K.; Shigeaki, N.; Hans, D.; Erik, O.; Capucine, P.; Jennifer, M. P.; Kate, S.; Mimi, L. K. T. Primary immunodeficiency diseases: An update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Proc. ICI Milan., 2014.
[6]
Wilcken, B. Recent advances in newborn screening. J. Inherit. Metab. Dis., 2007, 30(2), 129-133.
[http://dx.doi.org/10.1007/s10545-007-0538-6] [PMID: 17342450]
[7]
Chan, K.; Puck, J.M. Development of population-based newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol., 2005, 115(2), 391-398.
[http://dx.doi.org/10.1016/j.jaci.2004.10.012] [PMID: 15696101]
[8]
Kwan, A.; Abraham, R.S.; Currier, R.; Brower, A.; Andruszewski, K.; Abbott, J.K.; Baker, M.; Ballow, M.; Bartoshesky, L.E.; Bonilla, F.A.; Brokopp, C.; Brooks, E.; Caggana, M.; Celestin, J.; Church, J.A.; Comeau, A.M.; Connelly, J.A.; Cowan, M.J.; Cunningham-Rundles, C.; Dasu, T.; Dave, N.; De La Morena, M.T.; Duffner, U.; Fong, C.T.; Forbes, L.; Freedenberg, D.; Gelfand, E.W.; Hale, J.E.; Hanson, I.C.; Hay, B.N.; Hu, D.; Infante, A.; Johnson, D.; Kapoor, N.; Kay, D.M.; Kohn, D.B.; Lee, R.; Lehman, H.; Lin, Z.; Lorey, F.; Abdel-Mageed, A.; Manning, A.; McGhee, S.; Moore, T.B.; Naides, S.J.; Notarangelo, L.D.; Orange, J.S.; Pai, S.Y.; Porteus, M.; Rodriguez, R.; Romberg, N.; Routes, J.; Ruehle, M.; Rubenstein, A.; Saavedra-Matiz, C.A.; Scott, G.; Scott, P.M.; Secord, E.; Seroogy, C.; Shearer, W.T.; Siegel, S.; Silvers, S.K.; Stiehm, E.R.; Sugerman, R.W.; Sullivan, J.L.; Tanksley, S.; Tierce, M.L., IV; Verbsky, J.; Vogel, B.; Walker, R.; Walkovich, K.; Walter, J.E.; Wasserman, R.L.; Watson, M.S.; Weinberg, G.A.; Weiner, L.B.; Wood, H.; Yates, A.B.; Puck, J.M.; Bonagura, V.R. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA, 2014, 312(7), 729-738.
[http://dx.doi.org/10.1001/jama.2014.9132] [PMID: 25138334]
[9]
Barbaro, M.; Ohlsson, A.; Borte, S.; Jonsson, S.; Zetterström, R.H.; King, J.; Winiarski, J.; von Döbeln, U.; Hammarström, L. Newborn screening for severe primary immunodeficiency diseases in Sweden-a 2-year pilot TREC and KREC screening study. J. Clin. Immunol., 2017, 37(1), 51-60.
[http://dx.doi.org/10.1007/s10875-016-0347-5] [PMID: 27873105]
[10]
van Zelm, M.C.; Szczepanski, T.; van der Burg, M.; van Dongen, J.J. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J. Exp. Med., 2007, 204(3), 645-655.
[http://dx.doi.org/10.1084/jem.20060964] [PMID: 17312005]
[11]
Zetterström, R.; Barbaro, M.; Ohlsson, A.; Borte, S.; Jonsson, S.; Winiarski, J.; Ulrika, V.D.; Lennart, H. Newborn screening for primary immune deficiencies with a TREC/KREC/ACTB triplex assay—a three-year pilot study in Sweden. Int. J. Neonatal Screen., 2017, 3, 2-11.
[http://dx.doi.org/10.3390/ijns3020011]
[12]
Sottini, A.; Serana, F.; Bertoli, D.; Chiarini, M.; Valotti, M.; Vaglio Tessitore, M.; Imberti, L. Simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) by real-time PCR. J. Vis. Exp., 2014, 94(94), 3791-52184.
[http://dx.doi.org/10.3791/52184] [PMID: 25549107]
[13]
King, J.R.; Hammarström, L. Newborn screening for primary immunodeficiency diseases: history, current and future practice. J. Clin. Immunol., 2018, 38(1), 56-66.
[http://dx.doi.org/10.1007/s10875-017-0455-x] [PMID: 29116556]
[14]
Douek, D.C.; McFarland, R.D.; Keiser, P.H.; Gage, E.A.; Massey, J.M.; Haynes, B.F.; Polis, M.A.; Haase, A.T.; Feinberg, M.B.; Sullivan, J.L.; Jamieson, B.D.; Zack, J.A.; Picker, L.J.; Koup, R.A. Changes in thymic function with age and during the treatment of HIV infection. Nature, 1998, 396(6712), 690-695.
[http://dx.doi.org/10.1038/25374] [PMID: 9872319]
[15]
Routes, J.M.; Grossman, W.J.; Verbsky, J.; Laessig, R.H.; Hoffman, G.L.; Brokopp, C.D.; Baker, M.W. Statewide newborn screening for severe T-cell lymphopenia. JAMA, 2009, 302(22), 2465-2470.
[http://dx.doi.org/10.1001/jama.2009.1806] [PMID: 19996402]
[16]
Jyonouchi, S.; Jongco, A.M.; Puck, J.; Sullivan, K.E. Sul, l.; Ivan, K.E. Immunodeficiencies associated with abnormal newborn screening for T cell and B cell lymphopenia. J. Clin. Immunol., 2017, 37(4), 363-374.
[http://dx.doi.org/10.1007/s10875-017-0388-4] [PMID: 28353166]
[17]
Chien, Y.H.; Yu, H.H.; Lee, N.C.; Ho, H.C.; Kao, S.M.L.U. M.Y.; Tang-H.J.; Wen, I.L.; Kuei, W.C.; Chi, C.S.; Jiann, S.C; Shu, C.C.; Chen, C.L.; Wuh, L.H. Newborn screening for severe combined immunodeficiency in Taiwan. Int. J. Neonatal Screen., 2017, 3, 16.
[http://dx.doi.org/10.3390/ijns3030016]
[18]
Sottini, A.; Ghidini, C.; Zanotti, C.; Chiarini, M.; Caimi, L.; Lanfranchi, A.; Moratto, D.; Porta, F.; Imberti, L. Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin. Immunol., 2010, 136(2), 217-227.
[http://dx.doi.org/10.1016/j.clim.2010.04.005] [PMID: 20452829]
[19]
Fronkova, E.; Muzikova, K.; Mejstrikova, E.; Kovac, M.; Formankova, R.; Sedlacek, P.; Hrusak, O.; Stary, J.; Trka, J.; Trka, J. B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL. Bone Marrow Transplant., 2008, 42(3), 187-196.
[http://dx.doi.org/10.1038/bmt.2008.122] [PMID: 18490915]
[20]
Speckmann, C.; Neumann, C.; Borte, S.; la Marca, G.; Sass, J.O.; Wiech, E.; Fisch, P.; Schwarz, K.; Buchholz, B.; Schlesier, M.; Felgentreff, K.; Grimbacher, B.; Santisteban, I.; Bali, P.; Hershfield, M.S.; Ehl, S. Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis. J. Allergy Clin. Immunol., 2012, 130(4), 991-994.
[http://dx.doi.org/10.1016/j.jaci.2012.04.004] [PMID: 22578972]
[21]
Tsai, H.Y.; Yu, H.H.; Chien, Y.H.; Chu, K.H.; Lau, Y.L.; Lee, J.H.; Wang, L.C.; Chiang, B.L.; Yang, Y.H. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients. J. Microbiol. Immunol. Infect., 2015, 48(1), 113-118.
[http://dx.doi.org/10.1016/j.jmii.2012.07.004] [PMID: 23010537]
[22]
Zanotti, C.; Chiarini, M.; Serana, F.; Capra, R.; Rottoli, M.; Rovaris, M.; Cavaletti, G.; Clerici, R.; Rezzonico, M.; Caimi, L.; Imberti, L. Opposite effects of interferon-β on new B and T cell release from production sites in multiple sclerosis patients. J. Neuroimmunol., 2011, 240-241, 147-150.
[http://dx.doi.org/10.1016/j.jneuroim.2011.10.007] [PMID: 22078237]
[23]
Sottini, A.; Capra, R.; Zanotti, C.; Chiarini, M.; Serana, F.; Ricotta, D.; Caimi, L.; Imberti, L. Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient. PLoS One, 2012, 7(4)e34493
[http://dx.doi.org/10.1371/journal.pone.0034493] [PMID: 22496817]
[24]
Serana, F.; Sottini, A.; Chiarini, M.; Zanotti, C.; Ghidini, C.; Lanfranchi, A.; Notarangelo, L.D.; Caimi, L.; Imberti, L. The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency. J. Immunol., 2010, 185(12), 7713-7722.
[http://dx.doi.org/10.4049/jimmunol.1001770] [PMID: 21057082]
[25]
Mensen, A.; Ochs, C.; Stroux, A.; Wittenbecher, F.; Szyska, M.; Imberti, L.; Fillatreau, S.; Uharek, L.; Arnold, R.; Dörken, B.; Thiel, A.; Scheibenbogen, C.; Na, I.K. Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation. J. Transl. Med., 2013, 11, 188.
[http://dx.doi.org/10.1186/1479-5876-11-188] [PMID: 23941115]
[26]
Quiros-Roldan, E.; Serana, F.; Chiarini, M.; Zanotti, C.; Sottini, A.; Gotti, D.; Torti, C.; Caimi, L.; Imberti, L. Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients. J. Transl. Med., 2012, 10, 94.
[http://dx.doi.org/10.1186/1479-5876-10-94] [PMID: 22591651]
[27]
Nakagawa, N.; Imai, K.; Kanegane, H.; Sato, H.; Yamada, M.; Kondoh, K.; Okada, S.; Kobayashi, M.; Agematsu, K.; Takada, H.; Mitsuiki, N.; Oshima, K.; Ohara, O.; Suri, D.; Rawat, A.; Singh, S.; Pan-Hammarström, Q.; Hammarström, L.; Reichenbach, J.; Seger, R.; Ariga, T.; Hara, T.; Miyawaki, T.; Nonoyama, S. Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J. Allergy Clin. Immunol., 2011, 128(1), 223-225.e2.
[http://dx.doi.org/10.1016/j.jaci.2011.01.052] [PMID: 21397315]
[28]
van der Burg, M.; Mahlaoui, N.; Gaspar, H.B.; Pai, S.Y. Universal newborn screening for severe combined immunodeficiency (SCID). Front Pediatr., 2019, 7, 373.
[http://dx.doi.org/10.3389/fped.2019.00373] [PMID: 31620409]
[29]
Puck, J. Personal communication; University of California: San Francisco, CA, USA, . 2017.
[30]
Gaspar, H.B. A Practical Guide to Implementing Population Newborn Screening (NBS) for Severe Combined Immunodeficiency (SCID). Int. J. Neonatal Screen., 2017, 3, 29.
[http://dx.doi.org/10.3390/ijns3040029]
[31]
Hale, J.E.; Bonilla, F.A.; Pai, S.Y.; Gerstel-Thompson, J.L.; Notarangelo, L.D.; Eaton, R.B.; Comeau, A.M. Identification of an infant with severe combined immunodeficiency by newborn screening. J. Allergy Clin. Immunol., 2010, 126(5), 1073-1074.
[http://dx.doi.org/10.1016/j.jaci.2010.08.043] [PMID: 20933257]
[32]
Pai, S.Y.; Logan, B.R.; Griffith, L.M.; Buckley, R.H.; Parrott, R.E.; Dvorak, C.C.; Kapoor, N.; Hanson, I.C.; Filipovich, A.H.; Jyonouchi, S.; Sullivan, K.E.; Small, T.N.; Burroughs, L.; Skoda-Smith, S.; Haight, A.E.; Grizzle, A.; Pulsipher, M.A.; Chan, K.W.; Fuleihan, R.L.; Haddad, E.; Loechelt, B.; Aquino, V.M.; Gillio, A.; Davis, J.; Knutsen, A.; Smith, A.R.; Moore, T.B.; Schroeder, M.L.; Goldman, F.D.; Connelly, J.A.; Porteus, M.H.; Xiang, Q.; Shearer, W.T.; Fleisher, T.A.; Kohn, D.B.; Puck, J.M.; Notarangelo, L.D.; Cowan, M.J.; O’Reilly, R.J. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N. Engl. J. Med., 2014, 371(5), 434-446.
[http://dx.doi.org/10.1056/NEJMoa1401177] [PMID: 25075835]
[33]
Routes, J.; Verbsky, J. Newborn screening for severe combined immunodeficiency. Curr. Allergy Asthma Rep., 2018, 18(6), 34.
[http://dx.doi.org/10.1007/s11882-018-0783-9] [PMID: 29749587]
[34]
Rechavi, E.; Lev, A.; Saraf, L.T.; Etzioni, A.; Almashanu, S.; Somech, R. Newborn screening for severe combined immunodeficiency in Israel. Int. J. Neonatal Screen., 2017, 3, 2-13.
[http://dx.doi.org/10.3390/ijns3020013]
[35]
Lodi, L.; Ricci, S.; Romano, F.; Ghiori, F.; Canessa, C.; Lippi, F.; Bianchi, L.; Azzari, C. Newborn screening for PIDs using both TREC and KREC identifies late occurrence of B cells. Pediatr. Allergy Immunol., 2017, 28(5), 498-500.
[http://dx.doi.org/10.1111/pai.12733] [PMID: 28517432]
[36]
Deryabina, S.S.; Tuzankina, I.A.; Vlasova, E.V.; Lavrina, S.G.; Shershnev, V.N. Retrospective Diagnosis of Primary Immunodeficiences for Children in Sverdlovsk Region. Medical Immunology Russia., 2016, 18, 583-588.
[http://dx.doi.org/10.15789/1563-0625-2016-6-583-588]
[37]
Deryabina, S.S.; Tuzankina, I.A.; Shershnev, V.N. Determination of reference values for TREC and KREC in dry blood spots of newborns from different gestation ages in Sverdlovsk Region. Meditsinskaya immunologiya. Medical Immunology Russia., 2018, 20, 85-98.
[http://dx.doi.org/10.15789/1563-0625-2018-1-85-98]
[38]
Lingman Framme, J.; Borte, S.; von Döbeln, U.; Hammarström, L.; Oskarsdóttir, S. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome. J. Clin. Immunol., 2014, 34(4), 514-519.
[http://dx.doi.org/10.1007/s10875-014-0002-y] [PMID: 24610337]
[39]
Borte, S.; von Döbeln, U.; Fasth, A.; Wang, N.; Janzi, M.; Winiarski, J.; Sack, U.; Pan-Hammarström, Q.; Borte, M.; Hammarström, L. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood, 2012, 119(11), 2552-2555.
[http://dx.doi.org/10.1182/blood-2011-08-371021] [PMID: 22130802]
[40]
la Marca, G.; Canessa, C.; Giocaliere, E.; Romano, F.; Duse, M.; Malvagia, S.; Lippi, F.; Funghini, S.; Bianchi, L.; Della Bona, M.L.; Valleriani, C.; Ombrone, D.; Moriondo, M.; Villanelli, F.; Speckmann, C.; Adams, S.; Gaspar, B.H.; Hershfield, M.; Santisteban, I.; Fairbanks, L.; Ragusa, G.; Resti, M.; de Martino, M.; Guerrini, R.; Azzari, C. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency. J. Allergy Clin. Immunol., 2013, 131(6), 1604-1610.
[http://dx.doi.org/10.1016/j.jaci.2012.08.054] [PMID: 23280131]
[41]
Somech, R.; Lev, A.; Simon, A.J.; Korn, D.; Garty, B.Z.; Amariglio, N.; Rechavi, G.; Almashanu, S.; Zlotogora, J.; Etzioni, A. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study. Isr. Med. Assoc. J., 2013, 15(8), 404-409.
[PMID: 24079059]
[42]
Son, S.; Kang, J.M.; Kim, J.M.; Sung, S.; Kim, Y.S.; Lee, H.; Kim, Y.J. Lee, H.; Kim, B.A.; Lee, Y.K.; Ko, S.Y.; Shin, S.M.; Kim, Y.J. The First Newborn Screening Study of T-Cell Receptor Excision Circle and κ-Deleting Recombination Excision Circle for Severe Combined Immunodeficiency in Korea: A Pilot Study. Pediatr. Infect. Vaccine, 2017, 4, 134.
[http://dx.doi.org/10.14776/piv.2017.24.3.134]
[43]
Adams, S.P.; Rashid, S.; Premachandra, T.; Harvey, K.; Ifederu, A.; Wilson, M.C.; Gaspar, H.B. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J. Clin. Immunol., 2014, 34(3), 323-330.
[http://dx.doi.org/10.1007/s10875-014-0007-6] [PMID: 24668299]
[44]
Mallott, J.; Kwan, A.; Church, J.; Gonzalez-Espinosa, D.; Lorey, F.; Tang, L.F.; Sunderam, U.; Rana, S.; Srinivasan, R.; Brenner, S.E.; Puck, J. Newborn screening for SCID identifies patients with ataxia telangiectasia. J. Clin. Immunol., 2013, 33(3), 540-549.
[http://dx.doi.org/10.1007/s10875-012-9846-1] [PMID: 23264026]
[45]
Lima, K.; Abrahamsen, T.G.; Foelling, I.; Natvig, S.; Ryder, L.P.; Olaussen, R.W. Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles. Clin. Exp. Immunol., 2010, 161(1), 98-107.
[http://dx.doi.org/10.1111/j.1365-2249.2010.04152.x] [PMID: 20491792]
[46]
Morinishi, Y.; Imai, K.; Nakagawa, N.; Sato, H.; Horiuchi, K.; Ohtsuka, Y.; Kaneda, Y.; Taga, T.; Hisakawa, H.; Miyaji, R.; Endo, M.; Oh-Ishi, T.; Kamachi, Y.; Akahane, K.; Kobayashi, C.; Tsuchida, M.; Morio, T.; Sasahara, Y.; Kumaki, S.; Ishigaki, K.; Yoshida, M.; Urabe, T.; Kobayashi, N.; Okimoto, Y.; Reichenbach, J.; Hashii, Y.; Tsuji, Y.; Kogawa, K.; Yamaguchi, S.; Kanegane, H.; Miyawaki, T.; Yamada, M.; Ariga, T.; Nonoyama, S. Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards. J. Pediatr., 2009, 155(6), 829-833.
[http://dx.doi.org/10.1016/j.jpeds.2009.05.026] [PMID: 19628217]
[47]
Audrain, M.; Thomas, C.; Mirallie, S.; Bourgeois, N.; Sebille, V.; Rabetrano, H.; Fischer, A. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clin. Immunol., 2014, 9(150), 137.
[48]
Audrain, M.A.; Léger, A.J.C.; Hémont, C.A.F.; Mirallié, S.M.; Cheillan, D.; Rimbert, M.G.M.; Thomas, C.J.C. Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study). J. Clin. Immunol.,, 2018, 10, 0550-7..
[49]
Thomas, C.; Durand-Zaleski, I.; Frenkiel, J.; Mirallié, S.; Léger, A.; Cheillan, D.; Picard, C.; Mahlaoui, N.; Riche, V.P.; Roussey, M.; Sébille, V.; Rabetrano, H.; Dert, C.; Fischer, A.; Audrain, M. Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results. Clin. Immunol., 2019, 202, 33-39.
[http://dx.doi.org/10.1016/j.clim.2019.03.012] [PMID: 30946917]
[50]
Argudo, R.A. Martín, Nalda, A.; Marín-Soria, J.L.; López, alera, R. M.; Pajares-García, S.; González de Aledo-Castillo, J. M.; Soler-Palacín, P. First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Year’ Experience in Catalonia (Spain). Front. Immunol., 2019, •••, 10.
[51]
de Felipe, B.; Olbrich, P.; Lucenas, J.M.; Delgado-Pecellin, C.; Pavon-Delgado, A.; Marquez, J.; Salamanca, C.; Soler-Palacin, P.; Gonzalez-Granado, L.I.; Antolin, L.F.; Borte, S.; Neth, O. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville. Pediatr. Allergy Immunol., 2016, 27(1), 70-77.
[http://dx.doi.org/10.1111/pai.12501] [PMID: 26498110]
[52]
Blom, M.; Bredius, R.; Weijman, G.; Dekkers, E.; Kemper, E.; van den Akker-van Marle, M.; van der Ploeg, C.P.B.; van der Burg, M.; Schielen, C.J.I. Peter. Introducing newborn screening for severe combined immunodeficiency (SCID) in the Dutch neonatal screening program. Int. J. Neonatal Screen., 2018, 4, 1-10.
[http://dx.doi.org/10.3390/ijns4040040]
[53]
Van der Ploeg, C.P.B.; Blom, M.; Bredius, R.G.M.; van der Burg, M.; Schielen, P.C.J.I.; Verkerk, P.H. Van den Akker-van Marle, M.E. Cost-effectiveness of newborn screening for severe combined immunodeficiency. Eur. J. Pediatr., 2019, 178(5), 721-729.
[http://dx.doi.org/10.1007/s00431-019-03346-3] [PMID: 30805731]
[54]
Al-Mousa, H.; Al-Dakheel, G.; Jabr, A.; Elbadaoui, F.; Abouelhoda, M.; Baig, M.; Monies, D.; Meyer, B.; Hawwari, A.; Dasouki, M. High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots. Front. Immunol., 2018, 9, 782.
[http://dx.doi.org/10.3389/fimmu.2018.00782] [PMID: 29713328]
[55]
Berg, J.S.; Agrawal, P.B.; Bailey, D.B., Jr; Beggs, A.H.; Brenner, S.E.; Brower, A.M.; Cakici, A.F.J.; Ceyhan-Birsoy, O.; Chan, K.; Chen, F.; Currier, R.J.; Dukhovny, D.; Green, R.C.; Harris-Wai, J.; Holm, L.A.; Iglesias, B.; Joseph, G.; Kingsmore, S.F.; Koenig, B.A.; Kwok, Y.K.; Lantos, J.; Leeder, S.J.; Lewis, M.A.; McGuire, A.L.; Milko, L.V.; Mooney, S.D.; Parad, R.B.; Pereira, S.; Petrikin, J.; Powell, B.C.; Powell, C.M.; Puck, J.M.; Rehm, H.L.; Risch, N.; Roche, M.; Shieh, J.T.; Veeraraghavan, N.; Watson, M.S.; Willig, L.; Yu, T.M.; Urv, T.; Wise, A.L. Newborn sequencing in genomic medicine and public health. Pediatrics, 2017, 139, 2016-2252.
[56]
Chien, Y.H.; Chiang, S.C.; Chang, K.L.; Yu, H.H.; Lee, W.I.; Tsai, L.P.; Hsu, L.W.; Hu, M.H.; Hwu, W.L. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J. Formos. Med. Assoc., 2015, 114(1), 12-16.
[http://dx.doi.org/10.1016/j.jfma.2012.10.020] [PMID: 25618583]
[57]
Kanegae, M.P.P.; Barreiros, L.A.; Mazzucchelli, J.T.L.; Hadachi, S.M.; de Figueiredo Ferreira Guilhoto, L.M.; Acquesta, A.L.; Genov, I.R.; Holanda, S.M.; Di Gesu, R.S.; Goulart, A.L.; Dos Santos, A.M.; Bellesi, N.; Costa-Carvalho, B.T.; Condino-Neto, A. Neonatal screening for severe combined immunodeficiency in Brazil. J. Pediatr. (Rio J.), 2016, 92(4), 374-380.
[http://dx.doi.org/10.1016/j.jped.2015.10.006] [PMID: 27207231]
[58]
Rechavi, E.; Lev, A.; Simon, A.J.; Stauber, T.; Daas, S. First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency. Clinical Achievements and Insights., 2017, 8, 1-10.
[59]
Gordukova, M.A.; Oscorbin, I.P.; Mishukova, O.V.; Zimin, S.B.; Zinovieva, N.V.; Davydova, N.V.; Smirnova, A.S.; Nikitina, I.A.; Korsunsky, I.A.; Filipenko, M.L.; Prodeus, A.P. Development of real-time multiplex PCR for the quantitative determination of TREC’s and KREC’s in whole blood and in dried blood spots. Medical Immunology Russia., 2015, 17, 467-478.
[http://dx.doi.org/10.15789/1563-0625-2015-5-467-478]
[60]
Ding, Y.; Thompson, J.D.; Kobrynski, L.; Ojodu, J.; Zarbalian, G.; Grosse, S.D. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State. J. Pediatr., 2016, 172, 127-135.
[http://dx.doi.org/10.1016/j.jpeds.2016.01.029] [PMID: 26876279]
[61]
Bausch-Jurken, M.; Verbsky, J.; Routes, J. Newborn screening for severe combined immunodeficiency-a history of the TREC assay. Int. J. Neonatal Screen., 2017, 3, 14.
[http://dx.doi.org/10.3390/ijns3020014]
[62]
Ram, G.; Chinen, J. Infections and immunodeficiency in Down syndrome. Clin. Exp. Immunol., 2011, 164(1), 9-16.
[http://dx.doi.org/10.1111/j.1365-2249.2011.04335.x] [PMID: 21352207]
[63]
Baker, M.W.; Laessig, R.H.; Katcher, M.L.; Routes, J.M.; Grossman, W.J.; Verbsky, J.; Kurtycz, D.F.; Brokopp, C.D. Implementing routine testing for severe combined immunodeficiency within Wisconsin’s newborn screening program. Public Health Rep., 2010, 125(Suppl. 2), 88-95.
[http://dx.doi.org/10.1177/00333549101250S211] [PMID: 20518449]
[64]
Chiarini, M.; Zanotti, C.; Serana, F.; Sottini, A.; Bertoli, D.; Caimi, L.; Imberti, L. T-cell receptor and K-deleting recombination excision circles in newborn screening of T- and B-cell defects: review of the literature and future challenges. J. Public Health Res., 2013, 2(1), 9-16.
[http://dx.doi.org/10.4081/jphr.2013.e3] [PMID: 25170474]
[65]
Buckley, R.H. The long quest for neonatal screening for severe combined immunodeficiency. J. Allergy Clin. Immunol., 2012, 129(3), 597-604.
[http://dx.doi.org/10.1016/j.jaci.2011.12.964] [PMID: 22277203]
[66]
Chan, K.; Davis, J.; Pai, S-Y.; Bonilla, F.A.; Puck, J.M.; Apkon, M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol. Genet. Metab., 2011, 104(3), 383-389.
[http://dx.doi.org/10.1016/j.ymgme.2011.07.007] [PMID: 21810544]
[67]
McGhee, S.A.; Stiehm, E.R.; McCabe, E.R. Potential costs and benefits of newborn screening for severe combined immunodeficiency. J. Pediatr., 2005, 147(5), 603-608.
[http://dx.doi.org/10.1016/j.jpeds.2005.06.001] [PMID: 16291349]
[68]
Burgard, P.; Rupp, K.; Lindner, M.; Haege, G.; Rigter, T.; Weinreich, S.S.; Loeber, J.G.; Taruscio, D.; Vittozzi, L.; Cornel, M.C.; Hoffmann, G.F. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance. J. Inherit. Metab. Dis., 2012, 35(4), 613-625.
[http://dx.doi.org/10.1007/s10545-012-9484-z] [PMID: 22544437]
[69]
van der Spek, J.; Groenwold, R.H.H.; van der Burg, M.; van Montfrans, J.M. TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review. J. Clin. Immunol., 2015, 35(4), 416-430.
[http://dx.doi.org/10.1007/s10875-015-0152-6] [PMID: 25893636]
[70]
Shakerian, L.; Pourpak, Z.; Shamlou, S.; Domsgen, E.; Kazemnejad, A.; Dalili, H.; Nourizadeh, M. Determining Laboratory Reference Values of TREC and KREC in Different Age Groups of Iranian Healthy Individuals. Iran. J. Allergy Asthma Immunol., 2019, 18(2), 143-152.
[http://dx.doi.org/10.18502/ijaai.v18i2.917] [PMID: 31066250]
[71]
Kanegae, M.P.P.; Barreiros, L.A.; Sousa, J.L.; Brito, M.A.S.; Oliveira, E.B.; Soares, L.P.; Mazzucchelli, J.T.L.; Fernandes, D.Q.; Hadachi, S.M.; Holanda, S.M.; Guimarães, F.A.T.M.; Boacnin, M.A.P.V.V.; Pereira, M.A.L.; Bueno, J.M.C.; Grumach, A.S.; Gesu, R.S.W.D.; Santos, A.M.N.D.; Bellesi, N.; Costa-Carvalho, B.T.; Condino-Neto, A.F.A. Boacnin, Maura Aparecida P.V.V.; Pereira, L.M.A.; Bueno, J.M.C., Grumach, A.S, Gesu, Regina Sumiko W. Di.; Santos, Amélia Miyashiro N. dos.; Bellesi, N.; Costa-Carvalho, B.T.; Condino-Neto, A. Newborn screening for severe combined immunodeficiencies using trecs and krecs: second pilot study in brazil. Rev. Paul. Pediatr., 2017, 35(1), 25-32.
[http://dx.doi.org/10.1590/1984-0462/;2017;35;1;00013] [PMID: 28977313]
[72]
Nourizadeh, M.; Shakerian, L.; Borte, S.; Fazlollahi, M.; Badalzadeh, M.; Houshmand, M.; Alizadeh, Z.; Dalili, H.; Rashidi-Nezhad, A.; Kazemnejad, A.; Moin, M.; Hammarström, L.; Pourpak, Z. Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran. Scand. J. Immunol., 2018, 88, e12699..
[http://dx.doi.org/10.1111/sji.12699 ] [PMID: 2994347]
[73]
Verbsky, J.W.; Chatila, T.A. T-regulatory cells in primary immune deficiencies. Curr. Opin. Allergy Clin. Immunol., 2011, 11(6), 539-544.
[http://dx.doi.org/10.1097/ACI.0b013e32834cb8fa] [PMID: 21986549]
[74]
Cristina, G.M.; Anne, T.; Katja, V.; Markku, J.; David, M.H.; Jonas, B.G.; Marie, B.H.; Dea, A.; Galina, F.; Stephanie, D.; David, G.; Daniel, S. Rongcong. Wu: Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA. Int. J. Neonatal Screen., 2019, 5, 39.
[http://dx.doi.org/10.3390/ijns5040039]
[75]
Roifman, C.M.; Somech, R.; Kavadas, F.; Pires, L.; Nahum, A.; Dalal, I.; Grunebaum, E. Defining combined immunodeficiency. J. Allergy Clin. Immunol., 2012, 130(1), 177-183.
[http://dx.doi.org/10.1016/j.jaci.2012.04.029] [PMID: 22664165]
[76]
Kwan, A.; Church, J.A.; Cowan, M.J.; Agarwal, R.; Kapoor, N.; Kohn, D.B.; Lewis, D.B.; McGhee, S.A.; Moore, T.B.; Stiehm, E.R.; Porteus, M.; Aznar, C.P.; Currier, R.; Lorey, F.; Puck, J.M. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J. Allergy Clin. Immunol., 2013, 132(1), 140-150.
[http://dx.doi.org/10.1016/j.jaci.2013.04.024] [PMID: 23810098]